Hyperammonemia: An unusual presenting feature of multiple myeloma

Indian Journal of Medical Sciences

Volumn 59, Issue 1, 2005, Pages 24-27

  Shah, A S ^a   Shetty, N ^a   Jaiswal, S ^a   Mehta, B C ^a  

^a BSES MG Global Hospital   (India)

Author keywords

Hypercalcemia; Hyperviscosity; Sensorium

Indexed keywords

AMMONIA; MELPHALAN; PAMIDRONIC ACID; PREDNISOLONE;

AGED; AMMONIA BLOOD LEVEL; ANOREXIA; ARTICLE; BACKACHE; BLOOD VISCOSITY; CASE REPORT; CLINICAL FEATURE; EDEMA; FEMALE; FEMUR NECK FRACTURE; FEVER; FLAPPING TREMOR; HUMAN; HYPERAMMONEMIA; HYPERCALCEMIA; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; VERTEBRA FRACTURE;

EID: 13644270696     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.13815     Document Type: Article

References (7)

1. Matsuzaki H, Uchida M, Yoshimura K, Yoshida M, Akahoshi Y, Okazaki K, et al. Hyperammonemia in multiple myeloma. Acta Hematol 1990;84:130-4.
2. Durie B, Salmon S. A clinical staging system for multiple myeloma. Cancer 1975;36:842.
3. Bergsagel DE, Sprague CC, Austin C, Griffith KM. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma IV:I- phenylalanine mustard. Cancer Chemother Rev 1962;21:87.
4. Lokhorst H. Clinical features and diagnostic criteria. In: Jayesh Mehta and Seema Singhal, Ed. Myeloma. London: Martin Dunitz Ltd.; 2002. p. 151-68.
5. Matsuzaki H, Hata H, Sonoki T, Matsuno F, Kuribayashi N, Yoshida M, et al. Serum amino acid disturbance in multiple myeloma with hyperammonemia. Int J Hematol 1995;6:131-7.
6. Fujii S, Fukuda S, Sezaki T, Murakami M. Clinicopathological study of multiple myeloma associated with hyperammonemia. Rinsho Ketsueki 1998;39:27-33.
7. Otsuki T, Yamada O, Sakaguchi H, Ichiki T, Kouguchi K, Wada H, et al. In vitro excess ammonia production in human myeloma cell lines. Leukemia 1998;12:1149-58.